Antidepressants During Pregnancy May Increase Gestational Diabetes Risk: Study

Women taking antidepressant medications during pregnancy may face a higher risk of gestational diabetes, according to the findings of new research.

In a study published in the medical journal BMJ Open, Canadian researchers indicate that some antidepressants can increase the risk of gestational diabetes by more than 50%, which can lead to other more serious complications for both the mother and baby.

Researchers used data from the Quebec Pregnancy Cohort including data on all pregnancies and children in Quebec from January 1998 to December 2015.

Did You Know?

Ticketmaster Data Breach Impacts Millions of Customers

A massive Ticketmaster data breach exposed the names, addresses, phone numbers, credit card numbers and other personal information of more than 560 million customers, which have now been released on the dark web. Lawsuits are being pursued to obtain financial compensation.

Learn More

The study identified women who were more than 20 weeks pregnant and matched each person with 10 control cases. This included nearly 21,000 women who had gestational diabetes and 209,000 matched controls. Antidepressant exposure was assessed by filled prescriptions since the beginning of pregnancy.

Among the study participants, 4%, or roughly 10,000 women, took antidepressants during pregnancy. Roughly 1,100 of the women with gestational diabetes also took antidepressants.

According to the findings, those who took antidepressants had a higher likelihood of developing gestational diabetes. Short term use increased the risk by 15%, but long-term risk increased the risk by 29%.

Using serotonin norepinephrine reuptake inhibitors like Cymbalta or Effexor, or tricyclic antidepressants like Elavil also increase the risk. Patients who took Effexor had a 27% increased risk o gestational diabetes and those that took Elavil had a 52% increased risk.

Combining two types of antidepressants also increases the risk of gestational diabetes. However, there was no link between selective serotonin reuptake inhibitors (SSRIs), like Zoloft and Paxil, and gestational diabetes.

Gestational diabetes is a type of diabetes that develops during pregnancy and can increase the risk of complications a woman faces. Risks like high blood pressure, potentially needing a c-section, a drop in the baby’s blood sugar, or the child developing type 2 diabetes later in life are all increased if the mother develops gestational diabetes.

Prior studies have shown taking antidepressants during pregnancy can lead to other risks, including increased risk of preterm birth and increased risk the child may suffer from dyslexia or other language disorders. One study linked prenatal antidepressant use to increased risk of the child suffering from anxiety, ADHD, autism, and behavioral and mood disorders.

0 Comments

Share Your Comments

I authorize the above comments be posted on this page*

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades
Depo-Provera Meningioma Brain Tumors Risks May Have Been Ignored by Pfizer for Decades (Posted 4 days ago)

After decades of medical research and reported Depo-Provera side effects, Pfizer should have known that its birth control shot increases the risks of meningioma brain tumors, yet failed to warn women or the medical community.

Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto
Philadelphia Roundup Lawsuit Ends in Defense Verdict for Monsanto (Posted 4 days ago)

Bayer and Monsanto prevailed in a Roundup lawsuit that went to trial in Philadelphia this week, after a jury found that exposure to the herbicide did not cause a man to develop non-Hodgkin's lymphoma.